These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38355958)

  • 1. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
    Öfverholm A; Karlsson P; Rosén A
    Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
    Hawranek C; Rosén A; Hajdarevic S
    Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.
    Nääs C; von Salomé J; Rosén A
    Eur J Hum Genet; 2024 Apr; 32(4):448-455. PubMed ID: 38308085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population.
    Mendes Á; Sousa L
    Fam Cancer; 2012 Jun; 11(2):291-306. PubMed ID: 22367452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
    Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
    J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
    Gilmore MJ; Leo MC; Amendola LM; Goddard KAB; Ezzell Hunter J; Joseph G; Kauffman TL; Rolf B; Shuster E; Zepp JM; Wilfond BS; Biesecker BB
    Transl Behav Med; 2024 Jun; 14(7):377-385. PubMed ID: 38190737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
    Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
    J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.
    Andersson A; Hawranek C; Öfverholm A; Ehrencrona H; Grill K; Hajdarevic S; Melin B; Tham E; Hellquist BN; Rosén A
    Hered Cancer Clin Pract; 2020; 18():18. PubMed ID: 32944097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notification of a family history of breast cancer: issues of privacy and confidentiality.
    Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
    Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patients.
    Kerzin-Storrar L; Wright C; Williamson PR; Fryer A; Njindou A; Quarrell O; Donnai D; Craufurd D
    J Med Genet; 2002 Dec; 39(12):e85. PubMed ID: 12471223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.